Applications of Recombinant DNA Technology - PowerPoint PPT Presentation

1 / 39
About This Presentation
Title:

Applications of Recombinant DNA Technology

Description:

Applications of Recombinant DNA Technology – PowerPoint PPT presentation

Number of Views:4440
Avg rating:3.0/5.0
Slides: 40
Provided by: sharon112
Category:

less

Transcript and Presenter's Notes

Title: Applications of Recombinant DNA Technology


1
Applications of Recombinant DNA Technology
2
There are many different applications of DNA
technology
  • 1) Human disease gene mapping
  • Identifying genes with heritable variations that
    are associated with diseases of all kinds
  • 2) Prenatal and Presymptomatic testing
  • Developing probes for specific genetic
    variations that have been shown to be associated
    with diseases
  • 3) DNA fingerprinting for forensics and paternity
    testing
  • Harnessing the wealth of genetic variations held
    in repeat sequences to identify individuals

3
  • 4) Mapping the Human Genome
  • Combining cloning, DNA sequencing, and computing
    technologies to sequence 3 billion base pairs
  • 5) Gene therapy
  • Utilizing what we know about the genomes of
    bacterial and viral vectors to place specific
    genes in specific cell types
  • 6) Gene expression profiling
  • Creating microchips with 1000s of gene
    sequences on them to monitor gene expression
    patterns in cells and tumors

4
(No Transcript)
5
(No Transcript)
6
(No Transcript)
7
(No Transcript)
8
(No Transcript)
9
(No Transcript)
10
A1 A1 A1 A2 A1 A3 A2 A2 A2 A3
A3 A3
11
How do you suppose that people found these
variations?
And what were they good for? Hint Think back to
Mendel, Bateson, and Punnet but think from a
medical perspective
12
  • How do you suppose that people found these
    variations?
  • They screened lots of people with lots of probes
    and restriction enzymes
  • And what were they good for?
  • Linkage analysis and finding chromosomal regions
    that segregate with disease phenotypes.

13
Historical Aside How do you think people
figured out which genes were on which
chromosomes?
14
  • They used what information they had
  • For example, sometimes they were lucky to have a
    family that had the disease because of a
    chromosomal abnormality (usually a small but
    noticeable deletion)
  • Then when they found genes that were linked to
    the disease they knew they were near that
    chromosomal location
  • Then they looked for other genetic variation
    that was linked to the previous locus.
  • Now we have cool techniques like...
  • Fluorescence in situ hybridization
  • A technique involving labeling probes with
    fluorescent dyes and then hybridizing them to
    metaphase chromosomes.

15
http//www.ornl.gov/hgmis/graphics/slides/images3.
html
16
The Human Genome Project
17
What is the Human Genome Project?
  • U.S. govt. project coordinated by the Department
    of Energy and the National Institutes of Health
  • Goals (1998-2003)
  • Identify the approximate 100,000 genes in human
    DNA
  • Determine the sequences of the 3 billion bases
    that make up human DNA
  • Store this information in databases
  • Develop tools for data analysis
  • Address the ethical, legal, and social issues
    that arise from genome research

18
Why is the Department of Energy involved?
- After atomic bombs were dropped during War War
II, Congress told DOE to conduct studies to
understand the biological and health effects of
radiation and chemical by-products of all energy
production - Best way to study these effects is
at the DNA level
19
Whose genome is being sequenced?
  • The first reference genome is a composite genome
    from several different people
  • Generated from 10-20 primary samples taken from
    numerous anonymous donors across racial and
    ethnic groups

20
Benefits of HGP Research
  • Improvements in medicine
  • Microbial genome research for fuel and
    environmental cleanup
  • DNA forensics
  • Improved agriculture and livestock
  • Better understanding of evolution and human
    migration
  • More accurate risk assessment

21
Ethical, Legal, and Social Implications of HGP
Research
  • Fairness in the use of genetic information
  • Privacy and confidentiality
  • Psychological impact and stigmatization
  • Genetic testing
  • Reproductive issues
  • Education, standards, and quality control
  • Commercialization
  • Conceptual and philosophical implications

22
For More Information...
Human Genome Project Information
Website http//www.ornl.gov/hgmis
23
http//www.ornl.gov/hgmis/graphics/slides/images3.
html
24
http//www.ornl.gov/hgmis/graphics/slides/3lgenoba
.jpg
25
Microarray Technologies
26
http//www.nhgri.nih.gov/DIR/LCG/15K/HTML/images/a
rrayer_jpeg.jpg
27
The robotic setup includes 1) Glass slides
arranged in rows (about 5-10 per row) 2) The set
of cloned cDNA fragments to be put on the slides
(1000s of genes means lots of microtiter
dishes) 3) A robotic arm 4) A really good
computer 5) A really good program that directs
the process
28
http//www.medsch.ucla.edu/som/humgen/cores_dna.ht
m
29
http//www.medsch.ucla.edu/som/humgen/cores_dna.ht
m
30
http//genome-www.stanford.edu/molecularportraits/
31
From Lipshutz et al Nature Genetics Supplement
Vol 21, 1999
32
From Lipshutz et al Nature Genetics Supplement
Vol 21, 1999.
The chip consists of square features (cells,
probes) about 24x24 ?m for chips we use. They
come in perfect match (PM) - mismatch (MM) pairs
(probe pairs). 20 probe pairs per gene is
typical for expression arrays. We might expect
1,000,000 molecules of probe/feature. The
sequences are typically tiled with 1 bp overlaps
rather than spaced as shown here.
33
(No Transcript)
34
Gene expression profile of 55 samples based on
2518 genes. Red positive Green negative Black
zero
35
Clustering result from 2518 genes based on 75th
percentile expression gt200 and 50 of samples
with present call, using 50 knots for normalizing
the raw data.
W well M moderate P poor
1 stage 1 3 stage 3
CC clear cell PA papillary LA large cell NE
neuroendocrine MP mucinous/papillary BA
bronchioloalveolar BD bronchial-derived ACA BM
BD/mucinous MB mucinous/MA BB BA/BD
36
data stage and cluster X-square 3.1766, df
1, p-value 0.0747
data differentiation and cluster X-square
11.9501, df 2, p-value 0.0025
37
N Observed Expected (O-E)2/E
(O-E)2/V cluster1 23 13 6.5
6.51 10.9 cluster2 32 4 10.5
4.03 10.9 Chisq 10.9 on 1 degrees of
freedom, p 0.00097
38
N Observed Expected (O-E)2/E (O-E)2/V
stage1 35 6 11.62 2.72
8.79 stage3 20 11 5.38 5.87
8.79 Chisq 8.8 on 1 degrees of freedom, p
0.00302
39
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com